Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines

R. V. Patwardhan, M. C. Mitchell, R. F. Johnson, S. Schenker

Research output: Contribution to journalArticle

Abstract

The effects of oral contraceptive steroids (OCS) on the disposition and elimination of lorazepam, oxazepam, and chlordiazepoxide were examined. Lorazepam and oxazepam are metabolized via glucuronidation while chlordiazepoxide is metabolized by oxidation in the liver. The disposition and elimination of lorazepam, oxazepam, and chlordiazepoxide was studied in females not taking OCS and females taking OCS (norethindrone acetate, 1 mg; ethinyl estradiol, 50 μg) for 6 months or more. The t 1/2 (β) for lorazepam was significantly reduced in women taking OCS (6.0 ± 3.1 vs. 14.0 ± 6.2 hr) (p <0.005) as compared to controls, and the t 1/2 (β) for oxazepam was reduced in women taking OCS (7.71 ± 3.23 vs. 12.09 ± 5.08 hr) as compared to controls, but did not reach statistical significance. The plasma clearance of both lorazepam and oxazepam was significantly increased in women taking OCS [(288.9 ± 165.9 vs. 77.5 ± 3.29 ml per min) (p

Original languageEnglish (US)
Pages (from-to)248-253
Number of pages6
JournalHepatology
Volume3
Issue number2
StatePublished - 1983

Fingerprint

Oxazepam
Lorazepam
Oral Contraceptives
Benzodiazepines
Steroids
Chlordiazepoxide
Ethinyl Estradiol
Liver

ASJC Scopus subject areas

  • Hepatology

Cite this

Patwardhan, R. V., Mitchell, M. C., Johnson, R. F., & Schenker, S. (1983). Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines. Hepatology, 3(2), 248-253.

Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines. / Patwardhan, R. V.; Mitchell, M. C.; Johnson, R. F.; Schenker, S.

In: Hepatology, Vol. 3, No. 2, 1983, p. 248-253.

Research output: Contribution to journalArticle

Patwardhan, RV, Mitchell, MC, Johnson, RF & Schenker, S 1983, 'Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines', Hepatology, vol. 3, no. 2, pp. 248-253.
Patwardhan RV, Mitchell MC, Johnson RF, Schenker S. Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines. Hepatology. 1983;3(2):248-253.
Patwardhan, R. V. ; Mitchell, M. C. ; Johnson, R. F. ; Schenker, S. / Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines. In: Hepatology. 1983 ; Vol. 3, No. 2. pp. 248-253.
@article{6225fae994a54a4394af490f242a2c78,
title = "Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines",
abstract = "The effects of oral contraceptive steroids (OCS) on the disposition and elimination of lorazepam, oxazepam, and chlordiazepoxide were examined. Lorazepam and oxazepam are metabolized via glucuronidation while chlordiazepoxide is metabolized by oxidation in the liver. The disposition and elimination of lorazepam, oxazepam, and chlordiazepoxide was studied in females not taking OCS and females taking OCS (norethindrone acetate, 1 mg; ethinyl estradiol, 50 μg) for 6 months or more. The t 1/2 (β) for lorazepam was significantly reduced in women taking OCS (6.0 ± 3.1 vs. 14.0 ± 6.2 hr) (p <0.005) as compared to controls, and the t 1/2 (β) for oxazepam was reduced in women taking OCS (7.71 ± 3.23 vs. 12.09 ± 5.08 hr) as compared to controls, but did not reach statistical significance. The plasma clearance of both lorazepam and oxazepam was significantly increased in women taking OCS [(288.9 ± 165.9 vs. 77.5 ± 3.29 ml per min) (p",
author = "Patwardhan, {R. V.} and Mitchell, {M. C.} and Johnson, {R. F.} and S. Schenker",
year = "1983",
language = "English (US)",
volume = "3",
pages = "248--253",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines

AU - Patwardhan, R. V.

AU - Mitchell, M. C.

AU - Johnson, R. F.

AU - Schenker, S.

PY - 1983

Y1 - 1983

N2 - The effects of oral contraceptive steroids (OCS) on the disposition and elimination of lorazepam, oxazepam, and chlordiazepoxide were examined. Lorazepam and oxazepam are metabolized via glucuronidation while chlordiazepoxide is metabolized by oxidation in the liver. The disposition and elimination of lorazepam, oxazepam, and chlordiazepoxide was studied in females not taking OCS and females taking OCS (norethindrone acetate, 1 mg; ethinyl estradiol, 50 μg) for 6 months or more. The t 1/2 (β) for lorazepam was significantly reduced in women taking OCS (6.0 ± 3.1 vs. 14.0 ± 6.2 hr) (p <0.005) as compared to controls, and the t 1/2 (β) for oxazepam was reduced in women taking OCS (7.71 ± 3.23 vs. 12.09 ± 5.08 hr) as compared to controls, but did not reach statistical significance. The plasma clearance of both lorazepam and oxazepam was significantly increased in women taking OCS [(288.9 ± 165.9 vs. 77.5 ± 3.29 ml per min) (p

AB - The effects of oral contraceptive steroids (OCS) on the disposition and elimination of lorazepam, oxazepam, and chlordiazepoxide were examined. Lorazepam and oxazepam are metabolized via glucuronidation while chlordiazepoxide is metabolized by oxidation in the liver. The disposition and elimination of lorazepam, oxazepam, and chlordiazepoxide was studied in females not taking OCS and females taking OCS (norethindrone acetate, 1 mg; ethinyl estradiol, 50 μg) for 6 months or more. The t 1/2 (β) for lorazepam was significantly reduced in women taking OCS (6.0 ± 3.1 vs. 14.0 ± 6.2 hr) (p <0.005) as compared to controls, and the t 1/2 (β) for oxazepam was reduced in women taking OCS (7.71 ± 3.23 vs. 12.09 ± 5.08 hr) as compared to controls, but did not reach statistical significance. The plasma clearance of both lorazepam and oxazepam was significantly increased in women taking OCS [(288.9 ± 165.9 vs. 77.5 ± 3.29 ml per min) (p

UR - http://www.scopus.com/inward/record.url?scp=0020678824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020678824&partnerID=8YFLogxK

M3 - Article

C2 - 6131860

AN - SCOPUS:0020678824

VL - 3

SP - 248

EP - 253

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 2

ER -